101828-21-1CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12ABJKWBDEJIDSJZ-UHFFFAOYSA-NButenafine is trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections. It has a role as an EC 1.14.13.132 (squalene monooxygenase) inhibitor and an antifungal drug. It is a member of naphthalenes and a tertiary amine.
101828-21-1DTXSID7040657CHEMBL990CHEBI:3238Slightly soluble (HCl salt)
7.56e-05 g/L
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
D - Dermatologicals
QD - Dermatologicals
Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine's antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against <i>Candida albicans</i> and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for <i>Cryptococcus neoformans</i> and <i>Aspergillus spp.</i> as well.
Although the mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells.
91Y494NL0X
BUTENAFINE
Established Pharmacologic Class [EPC] - Benzylamine Antifungal
Chemical Structure [CS] - Benzylamines
Butenafine is a Benzylamine Antifungal.
UsesButenafine (Mentax) is a synthetic benzylamine antifungal agent, related structurally and pharmacologically to terbinafine. It is thought to act by inhibiting the enzyme squalene 2,3-epoxidase, resulting in decreased ergosterol and corresponding increase in squalene, with subsequent cell membrane permeability alteration and cell death. It is active against dermatophytes, yeast, and Sporothrix.
Preparation1. Using 1-naphthoic acid as a raw material, chlorination with thionyl chloride yields 1-naphthoyl chloride, which is then condensed with 1-(4-tert-butylbenzyl)-N-methylmethylamine to give N-(4-tert-butylbenzyl)-N-methyl-1-naphthoamide. This is followed by reduction with lithium aluminum hydride and salt formation to obtain butenafine hydrochloride. 2. Using p-tert-butylbenzoic acid as a raw material, chlorination with thionyl chloride yields p-tert-butylbenzoyl chloride, which is then condensed with N-methylnaphthylmethylamine to give 4-tert-butyl-N-methyl-N-(methylnaphthyl)benzamide. This is followed by reduction with lithium aluminum hydride and salt formation to obtain butenafine hydrochloride. 3. Using naphthalene as a raw material, chloromethylation synthesizes 1-chloromethylnaphthalene, which then reacts with methylamine to generate N-methylnaphthylmethylamine. This is followed by condensation with p-tert-butylbenzyl chloride and salt formation to obtain butenafine hydrochloride. 4. Starting with naphthalene, 1-chloromethylnaphthalene was prepared by chloromethylation, and then substituted with methylamine to obtain the key intermediate N-methyl-1-naphthylmethylamine hydrochloride. This was then condensed with p-tert-butylbenzyl chloride, followed by salt formation and recrystallization to obtain butenafine hydrochloride. 5. N-methyl-1-naphthylmethylamine hydrochloride (2) (41.5 g, 0.20 mol) was added to a mixture of toluene (150 ml) and 10% sodium hydroxide solution (160 g). The mixture was heated to 80 °C, and p-tert-butylbenzyl chloride (3) (40.2 g, 0.22 mol) was added dropwise with stirring over approximately 1 hour. The reaction was continued with stirring for 3 hours. The reaction was stopped, and the organic layer was separated after cooling to room temperature. The organic layer was washed with water until neutral and dried with anhydrous sodium sulfate. After filtration, the toluene was recovered, and the residue was dissolved in an appropriate amount of ethanol. The pH was adjusted to 2 with concentrated hydrochloric acid, and the solvent was recovered to obtain a white crude product (59.8 g). Recrystallization with 50% ethanol yields a white, pure product 1.
DefinitionChEBI: Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in funga cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.